Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Stereotactic Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02252796
What this trial is testing

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
West Virginia University 1
Testing effectiveness (Phase 2)UnknownNCT01795521
What this trial is testing

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage II
European Organisation for Research and Treatment of Cancer - EORTC 39
Not applicableUnknownNCT02950337
What this trial is testing

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Loyola University 41
Testing effectiveness (Phase 2)UnknownNCT04306926
What this trial is testing

TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced Oligometastatic Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 59
Testing effectiveness (Phase 2)Study completedNCT02314364
What this trial is testing

A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

Who this might be right for
Non-small Cell Lung Cancer MetastaticTargetable Oncogenes (EGFR, ALK, ROS1)
Massachusetts General Hospital 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06434740
What this trial is testing

SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Sir Run Run Shaw Hospital 37
Testing effectiveness (Phase 2)UnknownNCT04840758
What this trial is testing

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

Who this might be right for
Multiple Primary Lung Cancer
The First Affiliated Hospital of Xiamen University 39
Testing effectiveness (Phase 2)Looking for participantsNCT06542159
What this trial is testing

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases

Who this might be right for
Adaptive RadiotherapyStereotactic Body RadiotherapyNon-small Cell Lung Cancer+2 more
Sun Yat-sen University 130
Not applicableStudy completedNCT05291780
What this trial is testing

Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell Carcinoma
Radiotherapy Oncology Centre "Santa Maria" Hospital 80
Large-scale testing (Phase 3)UnknownNCT00268684
What this trial is testing

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Tel-Aviv Sourasky Medical Center 381
Very early researchStudy completedNCT05555342
What this trial is testing

A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm

Who this might be right for
Lung TumorMetastatic Cancer
University of California, Irvine 6
Testing effectiveness (Phase 2)UnknownNCT06391008
What this trial is testing

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Who this might be right for
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44
Not applicableStudy completedNCT02559349
What this trial is testing

Gut Microbiota And Radiotherapy

Who this might be right for
Lung Tumor
Abramson Cancer Center at Penn Medicine 10
Not applicableStudy completedNCT01656460
What this trial is testing

Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer

Who this might be right for
Lung Cancer
Dr Thomas DiPetrillo 12
Early research (Phase 1)Temporarily pausedNCT05403723
What this trial is testing

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
University of Maryland, Baltimore 50
Testing effectiveness (Phase 2)Study completedNCT04021043
What this trial is testing

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Carcinoma in the LiverMetastatic Carcinoma in the Lung+2 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07167459
What this trial is testing

Personalized SBRT in Early-Stage Peripheral NSCLC

Who this might be right for
Early-stage Peripheral Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 251
Testing effectiveness (Phase 2)Study completedNCT03825510
What this trial is testing

Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

Who this might be right for
Metastatic Nonsmall Cell Lung CancerNon Small Cell Lung Cancer
Crozer-Keystone Health System 3
Testing effectiveness (Phase 2)UnknownNCT02224547
What this trial is testing

Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System

Who this might be right for
Non-Small Cell Lung Carcinoma
Universitair Ziekenhuis Brussel 58
Not applicableLooking for participantsNCT07401615
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions

Who this might be right for
Non Small Cell Lung CancerPulmonary Stereotactic Radiotherapy
Istituto Clinico Humanitas 150
Next Page